Impact of Current Antipsychotic Medications on Comparative Mortality and Adverse Events in People With Parkinson Disease Psychosis-Reference-Cited by-同舟云学术

Impact of Current Antipsychotic Medications on Comparative Mortality and Adverse Events in People With Parkinson Disease Psychosis

Published:2015-10 Issue:10 Volume:16 Page:898.e1-898.e7
ISSN:1525-8610
Container-title:Journal of the American Medical Directors Association
language:en
Short-container-title:Journal of the American Medical Directors Association

Author:

Ballard Clive,Isaacson Stuart,Mills Roger,Williams Hilde,Corbett Anne,Coate Bruce,Pahwa Rajesh,Rascol Olivier,Burn David J.

Publisher

Elsevier BV

Subject

Health Policy,General Medicine,General Nursing,Geriatrics and Gerontology

Reference26 articles.

1. Parkinson's Disease Foundation, Inc. Statistics on Parkinson's. New York, NY. Available at: http://www.pdf.org/en/parkinson_statistics. Accessed August 13, 2014.

2. Psychiatric syndromes in Parkinson's disease;Starkstein;Curr Opin Psychiatry,2012

3. A comparative study of psychiatric symptoms in dementia with Lewy bodies and Parkinson's disease with and without dementia;Aarsland;Int J Geriatr Psychiatry,2001

4. Clozapine in drug-induced psychosis in Parkinson's disease;Lancet,1999

5. Low-dose clozapine for the treatment of drug-induced psychosis in Parkinson's disease;N Engl J Med,1999

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risperidone-induced bioenergetic disruption in the isolated human peripheral blood monocytes;Toxicology in Vitro;2024-12

2. Implications of Pimavanserin in Patients with Dementia-related Psychosis: A Systematic Review;Journal of Medical Sciences;2024-04-27

3. Safety Profile of Pimavanserin Therapy in Elderly Patients with Neurodegenerative Disease-Related Neuropsychiatric Symptoms: A Phase 3B Study;Journal of Alzheimer's Disease;2024-03-05

4. Retrospective analyses evaluating the mortality risk associated with pimavanserin or other atypical antipsychotics in patients with Parkinson disease psychosis;Clinical Parkinsonism & Related Disorders;2024

5. Neuropsychiatric Manifestations in Alzheimer’s Disease Patients: Genetics and Treatment Options;CNS & Neurological Disorders - Drug Targets;2024-01